These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6187915)

  • 21. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal exposure to methamphetamine in utero stimulates development of serotonergic neurons in three-dimensional reaggregate tissue culture.
    Won L; Bubula N; Heller A
    Synapse; 2002 Feb; 43(2):139-44. PubMed ID: 11754494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry.
    Sabol KE; Richards JB; Yung K
    J Pharmacol Exp Ther; 2000 Sep; 294(3):850-63. PubMed ID: 10945833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamic changes of brain serotonergic and dopaminergic activities during development of anxious depression: experimental study].
    Avgustinovich DF; Alekseenko OV; Bakshtanovskaia IV; Koriakina LA; Lipina TV; Tenditnik MV; Bondar' NP; Kovalenko IL; Kudriavtseva NN
    Usp Fiziol Nauk; 2004; 35(4):19-40. PubMed ID: 15573884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats.
    Kurling S; Kankaanpää A; Ellermaa S; Karila T; Seppälä T
    Brain Res; 2005 May; 1044(1):67-75. PubMed ID: 15862791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine-induced neural and cognitive changes in rodents.
    Marshall JF; Belcher AM; Feinstein EM; O'Dell SJ
    Addiction; 2007 Apr; 102 Suppl 1():61-9. PubMed ID: 17493054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between brain levels and biochemical effects of the optical isomers of p-chloroamphetamine.
    Sekerke HJ; Smith HE; Bushing JA; Sanders-Bush E
    J Pharmacol Exp Ther; 1975 Jun; 193(3):835-44. PubMed ID: 1151732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
    Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
    J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cocaine on methamphetamine-induced neurochemical changes: characterization of cocaine as a monoamine uptake blocker.
    Hanson GR; Matsuda LA; Gibb JW
    J Pharmacol Exp Ther; 1987 Aug; 242(2):507-13. PubMed ID: 2886643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pethidine on central neurotransmitters: changes in the state of tolerance.
    Nowakowska E; Chodera A; Szczawińska K; Cenajek D
    Pol J Pharmacol Pharm; 1986; 38(2):143-8. PubMed ID: 2428018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity.
    Elayan I; Gibb JW; Hanson GR; Lim HK; Foltz RL; Johnson M
    J Pharmacol Exp Ther; 1993 May; 265(2):813-8. PubMed ID: 8496826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
    Schmidt CJ; Gibb JW
    Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurochemical effects of cocaine following acute and repeated injection.
    Taylor D; Ho BT
    J Neurosci Res; 1977; 3(2):95-101. PubMed ID: 202724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.
    Johnson M; Stone DM; Hanson GR; Gibb JW
    Eur J Pharmacol; 1987 Mar; 135(2):231-4. PubMed ID: 2884120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of tolerance to methamphetamine-induced monoamine deficits.
    Danaceau JP; Deering CE; Day JE; Smeal SJ; Johnson-Davis KL; Fleckenstein AE; Wilkins DG
    Eur J Pharmacol; 2007 Mar; 559(1):46-54. PubMed ID: 17239369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.